Participated · Series B · Apr 2026

Manna Air Delivery operates a regulated consumer drone delivery network using proprietary software and hardware to deliver everyday items in minutes to suburban customers. The company has completed more than 250,000 regulated commercial UAV flights, holds a Gold Standard Light UAS Operator Certificate under EASA, and employs over 170 staff. Manna reports deliveries in under three minutes, an NPS of 86, and claims CO2 emissions reductions of up to 85% versus road-based delivery. It currently operates in Ireland, Finland and Texas and has partnerships with platforms including Uber, Deliveroo, Just Eat and DoorDash. Founded in 2019, Manna positions itself as an infrastructure provider for instant logistics and plans to scale to as many as 40 bases in the United States with the new funding.

Led · Equity · Mar 2026

KEWAZO builds robotics and AI solutions for heavy-industry material movement, with its flagship product LIFTBOT designed to replace cranes and manual handling. LIFTBOT is deployed at more than 20 sites across North America and Europe, including refineries, petrochemical plants, chemical facilities, and power plants. The company leverages operational deployments to collect structured data and is developing a broader Physical AI platform to drive further automation and transparency across industrial workflows. KEWAZO positions its technology to improve safety, increase efficiency, and enhance schedule predictability for maintenance, turnaround, and capital projects. The company has raised a total of $35 million in funding and plans to use the new capital to expand deployment capacity, extend into additional workflows, and deepen customer integrations. KEWAZO operates from Munich and Houston and counts both traditional venture investors and strategic corporate investors among its backers.

Participated · Series A · Mar 2026

Carecubes develops the Carecube ISTARI, an FDA 510(k)-cleared isolation unit built for rapid deployment to enable safe bedside care while isolating pathogens. The product was developed in partnership with infectious disease experts at the University of Nebraska Medical Center and initially funded by DARPA with further support from the CDC and ASPR. Carecubes reports commercial traction, with purchases by hospitals, clinics, and emergency response systems in over 36 communities across 13 states and territories and named customers including Bellevue Hospital of NYC Health+Hospitals and Providence Sacred Heart Medical Center. The company manufactures the units in Minnesota and works with suppliers and partners across multiple U.S. states. Leadership includes CEO Alex Laskey and co-founder Saul Griffith, and the organization has assembled a board and advisors with deep healthcare operations experience. The company announced a $6.5 million Series A in March 2026 to advance its deployment and scale, though the release did not disclose specific revenue figures or a valuation.

Participated · Equity · May 2025

Remedy Plan Therapeutics develops novel, hyperbolic NAMPT inhibitors intended to inhibit disease-associated NAMPT activity without fully turning the enzyme off, thereby avoiding on-target toxicity in healthy tissues. The company’s lead candidate is RPT1G. Remedy Plan plans to use recent financing to accelerate advancement of RPT1G into a Phase 1/2 trial in patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS). It says NAMPT is dysregulated in more than 20 diseases spanning oncology, autoimmunity, and metabolic disorders. Remedy Plan is a privately-held, clinical-stage company led by CEO and founder Greg Crimmins and is based in Gaithersburg, MD. The company cites prior failures of NAMPT inhibitors due to severe on-target toxicities and positions its approach as selectively avoiding those toxicities while still meaningfully inhibiting diseased cells.

Led · Series A · May 2025

Onebeat offers a dynamic inventory optimization and execution platform that converts replenishment, allocation, and liquidation into daily SKU‑store level decisions. Its software enables retailers to act quickly, adapt in real time, and maximize profitability through precise inventory flow. The platform is already used by more than 220 retailers worldwide. Led by CEO Dr. Yishai Ashlag, Onebeat is headquartered in New York City. The company plans to use new funding to expand operations and accelerate development efforts. Recent fundraising activity brought its total funding to $30M. Onebeat is a Tel Aviv-based AI-enabled retail-tech company offering a SaaS solution that gives mid-market retailers flexibility and improved inventory visibility. Founded in 2018 by Dr. Yishai Ashlag (CEO) and Avihai Shnabel, the company was born out of Goldratt Consulting. Its platform is designed to help retailers cut costs and expand margins using AI-driven supply-chain and inventory capabilities. During the last twelve months Onebeat more than doubled its client base, now partnering with over 170 retailers across 26 countries in sectors including fashion, footwear, jewelry, pharmacy and beverage. The company works with global retail leaders such as Calvin Klein, American Eagle, Crocs and the retail division of TATA Group. Onebeat raised an additional $10M and plans to use the funds to expand its retail platform, business operations and pursue new business growth plans.